Consensus LeMaitre Vascular, Inc. Börse Stuttgart

Stocks

LHU

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Börse Stuttgart 15:55:37 2026-08-14 EDT			5-day change	1st Jan Change
70.50 ^EUR	-0.70%		+2.90%	+1.43%

08-06	Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95	MT
08-05	Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform	MT

Evolution of the Average Target: LeMaitre Vascular, Inc.

Evolution of the Target Price: LeMaitre Vascular, Inc.

Changes in Analyst Recommendations: LeMaitre Vascular, Inc.

0042080ad5.aU2bFv72AvxOwJjYYnOAZ6ciG5FEQ42549xWvNMrS9U.Gir9Jq-QbYwpo_6CND_hHcgUROsqEdzh1oQM0aFaOpQxJqNVr486sxv32Q~3c846d9360d504b40684a07b4f4009ad

Analysts' recommendations: LeMaitre Vascular, Inc.

08-06	Barrington Upgrades LeMaitre Vascular to Outperform From Market Perform, Price Target is $95	MT
08-05	Barrington Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
05-06	Barrington Adjusts Price Target on LeMaitre Vascular to $120 From $105, Maintains Outperform Rating	MT
02-26	LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results	MT
02-26	Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating	MT
25-08-05	Medical device firm LeMaitre Q2 sales beat expectations	RE
25-02-28	Oppenheimer Downgrades LeMaitre Vascular to Market Perform From Overweight, Price Target is $45	MT
25-02-13	Wells Fargo Initiates LeMaitre Vascular at Equalweight With $95 Price Target	MT
24-10-15	Cantor Fitzgerald Initiates LeMaitre Vascular at Neutral With $96 Price Target	MT
24-05-31	Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	MT
24-05-03	Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating	MT
24-04-26	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	MT
24-02-28	Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	MT
23-10-23	JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	MT
23-09-06	Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	MT
23-08-03	Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	MT
23-08-02	Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	MT
23-05-03	Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	MT
23-05-03	Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	MT
23-05-03	Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	MT
23-05-03	Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	MT
22-10-28	Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
22-04-29	Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	MT
22-02-25	Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	MT
21-10-29	Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
LEMAITRE VASCULAR, INC.	-	-	-	-
THERMO FISHER SCIENTIFIC, INC.				+7.33%
DANAHER CORPORATION				+12.6%
INTUITIVE SURGICAL, INC.				+21.17%
BOSTON SCIENTIFIC CORPORATION				+20.95%
EDWARDS LIFESCIENCES CORPORATION				+10.22%
SIEMENS HEALTHINEERS AG				+14.59%
AGILENT TECHNOLOGIES, INC.				+7.79%
WATERS CORPORATION				+5.78%
GE HEALTHCARE TECHNOLOGIES INC.				+11.96%
Average				+12.49%
Weighted average by Cap.				+12.79%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

82.38USD

Average target price

107.00USD

Spread / Average Target

+29.89%

High Price Target

132.00USD

Spread / Highest target

+60.23%

Low Price Target

81.00USD

Spread / Lowest Target

-1.68%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barrington Research
Oppenheimer
Wells Fargo Securities
Cantor Fitzgerald
Roth MKM
Stifel Nicolaus
JMP Securities
Jefferies & Co.
Roth Capital Partners
KeyBanc Capital Markets